These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16344496)

  • 1. Modification of hypertension and hypercholesterolaemia in patients with systemic lupus erythematosus: a quality improvement study.
    Urowitz MB; Gladman DD; Ibanez D; Berliner Y
    Ann Rheum Dis; 2006 Jan; 65(1):115-7. PubMed ID: 16344496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study.
    Bruce IN; Gladman DD; Urowitz MB
    Clin Exp Rheumatol; 1998; 16(4):435-40. PubMed ID: 9706424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study.
    Kanaki AI; Sarafidis PA; Georgianos PI; Stafylas PC; Kanavos K; Tziolas IM; Lasaridis AN
    J Hum Hypertens; 2012 Oct; 26(10):577-84. PubMed ID: 21881597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of hypercholesterolemia in systemic lupus erythematosus.
    Bruce IN; Urowitz MB; Gladman DD; Hallett DC
    J Rheumatol; 1999 Oct; 26(10):2137-43. PubMed ID: 10529129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypercholesterolemia and hypertension--equivalent risk factors?].
    Kaufmann G
    Schweiz Rundsch Med Prax; 1991 Nov; 80(46):1272-7. PubMed ID: 1957090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS; Poulter NR; Dahlof B; Wedel H;
    J Hypertens; 2009 May; 27(5):947-54. PubMed ID: 19318984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The "healthy" patient with hypercholesterolemia].
    Klose G
    Med Klin (Munich); 2005 Feb; 100(2):99-106; quiz 107-8. PubMed ID: 15711905
    [No Abstract]   [Full Text] [Related]  

  • 8. Vascular events in hypertensive patients with systemic lupus erythematosus.
    Rahman P; Aguero S; Gladman DD; Hallett D; Urowitz MB
    Lupus; 2000; 9(9):672-5. PubMed ID: 11199921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary artery angiography in systemic lupus erythematosus patients with abnormal myocardial perfusion scintigraphy.
    Sella EM; Sato EI; Barbieri A
    Arthritis Rheum; 2003 Nov; 48(11):3168-75. PubMed ID: 14613279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study.
    Bruce IN; Urowitz MB; Gladman DD; Ibañez D; Steiner G
    Arthritis Rheum; 2003 Nov; 48(11):3159-67. PubMed ID: 14613278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study).
    Olkinuora JT; Viikari J; Vanhanen H; Makkonen N; Kalliomäki T
    Scand Cardiovasc J; 2006 Jun; 40(3):160-6. PubMed ID: 16798663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hypertension and hypercholesterolaemia in primary care in The Netherlands.
    van Wyk JT; Picelli G; Dieleman JP; Mozaffari E; Kramarz P; van Wijk MA; van der Lei J; Sturkenboom MC
    Curr Med Res Opin; 2005 Jun; 21(6):839-48. PubMed ID: 15969884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus.
    Rahman P; Urowitz MB; Gladman DD; Bruce IN; Genest J
    J Rheumatol; 1999 Nov; 26(11):2363-8. PubMed ID: 10555892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin reduces sympathetic activity and increases baroreceptor reflex sensitivity in patients with hypercholesterolaemia and systemic arterial hypertension.
    Siński M; Lewandowski J; Ciarka A; Bidiuk J; Abramczyk P; Dobosiewicz A; Gaciong Z
    Kardiol Pol; 2009 Jun; 67(6):613-20. PubMed ID: 19618317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus.
    McLaurin EY; Holliday SL; Williams P; Brey RL
    Neurology; 2005 Jan; 64(2):297-303. PubMed ID: 15668428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol levels in untreated Spanish hypertensive patients. The Compas Study Group, Spanish Hypertension Society.
    Aranda P; Rodicio JL; Luque M; Banegas JR; Barajas R; Aranda FJ; Sobrino P
    Blood Press; 1999; 8(5-6):273-8. PubMed ID: 10803487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertensive disease in pregnancies complicated by systemic lupus erythematosus.
    Egerman RS; Ramsey RD; Kao LW; Bringman JJ; Bush AJ; Wan JY
    Am J Obstet Gynecol; 2005 Nov; 193(5):1676-9. PubMed ID: 16260209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery disease in systemic lupus erythematosus: A review of the literature.
    Karrar A; Sequeira W; Block JA
    Semin Arthritis Rheum; 2001 Jun; 30(6):436-43. PubMed ID: 11404827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.